Ratti Ram Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ratti Ram Sharma has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Suchet Sachdev
Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
3 shared publications - Arindam Chatterjee
Council of Scientific and Industrial Research–Central Scientific Instruments Organization (CSIR-CSIO), Chandigarh, India
2 shared publications - Gurinderjit Singh
Council of Scientific and Industrial Research–Central Scientific Instruments Organization (CSIR-CSIO), Chandigarh, India
2 shared publications - Prateek Bhatia
Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 shared publications - Sanjeev Verma
Council of Scientific and Industrial Research–Central Scientific Instruments Organization (CSIR-CSIO), Chandigarh, India
2 shared publications - Sarbjeet Singh
Council of Scientific and Industrial Research–Central Scientific Instruments Organization (CSIR-CSIO), Chandigarh, India
2 shared publications
Latest Publications
- 22 December 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (1) , 32
Change in composition of blood after passing through circuit of automated device versus manual clinical method for neonatal exchange transfusions
We previously developed and published a novel device to automate double volume exchange transfusions (DVET) via the umbilical venous catheter (UVC) in neonates. Prior to initiating clinical trials, we aimed to demonstrate that alterations in blood composition after passage through our device’s circuit were not greater than those seen with the conventional manual method. We performed five ex vivo simulations of neonatal DVET using donor blood in standard blood bank bags and our automated device. Samples were obtained from the blood bag at baseline and from the distal end of the circuit after completion of 50% and 100% of the simulated DVET. These were analyzed for hematological, biochemical, and blood gas parameters, osmolality, and culture. For comparison, four manual DVETs were similarly performed, with corresponding sample collection and analyses. Deviations of laboratory parameters at the 50% and 100% time points that were > ± 25% from baseline were classified as major. The proportion of major deviations was compared between automated and manual DVETs. Automated DVETs demonstrated significantly fewer major deviations than manual DVETs in hematological parameters [15/156 (9.61%) vs. 28/124 (22.58%), p = 0.0048], biochemical parameters [0/120 (0%) vs. 32/88 (36.36%), p < 0.0001], and blood gas values [11/50 (22.0%) vs. 20/40 (50.0%), p = 0.011]. Notably, the blood used in automated DVETs was significantly older than that used in the manual group. Conclusion: Automated DVET using our novel device results in fewer compositional deviations from baseline compared to conventional manual DVET, supporting its potential clinical utility. What is Known: • Our research group previously developed and published a novel electromechanical device to perform double volume exchange transfusions (DVET) in neonates through the umbilical venous route. • Previous authors who had made automated devices did not analyze the composition of the blood exiting the device circuit (“post-circuit” composition), nor compared this to the conventional manual method of exchange transfusions. What is New: • In simulated DVETs performed with our device, there were significantly fewer changes in the post-circuit composition of the blood from baseline (hematological, biochemical, blood gas and osmolality values) compared to manual DVETs. • Among DVETs performed manually, 7 ml aliquots per cycle were associated with greater changes in the post-circuit composition of the blood compared to 10 ml aliquots per cycle.
- 22 December 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (1) , 32
Change in composition of blood after passing through circuit of automated device versus manual clinical method for neonatal exchange transfusions
We previously developed and published a novel device to automate double volume exchange transfusions (DVET) via the umbilical venous catheter (UVC) in neonates. Prior to initiating clinical trials, we aimed to demonstrate that alterations in blood composition after passage through our device’s circuit were not greater than those seen with the conventional manual method. We performed five ex vivo simulations of neonatal DVET using donor blood in standard blood bank bags and our automated device. Samples were obtained from the blood bag at baseline and from the distal end of the circuit after completion of 50% and 100% of the simulated DVET. These were analyzed for hematological, biochemical, and blood gas parameters, osmolality, and culture. For comparison, four manual DVETs were similarly performed, with corresponding sample collection and analyses. Deviations of laboratory parameters at the 50% and 100% time points that were > ± 25% from baseline were classified as major. The proportion of major deviations was compared between automated and manual DVETs. Automated DVETs demonstrated significantly fewer major deviations than manual DVETs in hematological parameters [15/156 (9.61%) vs. 28/124 (22.58%), p = 0.0048], biochemical parameters [0/120 (0%) vs. 32/88 (36.36%), p < 0.0001], and blood gas values [11/50 (22.0%) vs. 20/40 (50.0%), p = 0.011]. Notably, the blood used in automated DVETs was significantly older than that used in the manual group. Conclusion: Automated DVET using our novel device results in fewer compositional deviations from baseline compared to conventional manual DVET, supporting its potential clinical utility. What is Known: • Our research group previously developed and published a novel electromechanical device to perform double volume exchange transfusions (DVET) in neonates through the umbilical venous route. • Previous authors who had made automated devices did not analyze the composition of the blood exiting the device circuit (“post-circuit” composition), nor compared this to the conventional manual method of exchange transfusions. What is New: • In simulated DVETs performed with our device, there were significantly fewer changes in the post-circuit composition of the blood from baseline (hematological, biochemical, blood gas and osmolality values) compared to manual DVETs. • Among DVETs performed manually, 7 ml aliquots per cycle were associated with greater changes in the post-circuit composition of the blood compared to 10 ml aliquots per cycle.
- Open Access
- 1 January 2024
- Published by Medknow in Asian Journal of Transfusion Science
- Vol. 18 (1) , 124-127
Donor lymphocyte infusions: An experience from a tertiary care center of North India
Donor lymphocyte infusions (DLIs) are often recommended products after allogeneic hematopoietic stem cell transplant to increase graft – versus – leukemia effect. More success rate of DLI has been reported in relapsed posttransplant chronic myeloid leukemia. Whatever the indication for DLI, mortality related to post-DLI infusion is 5%–20%, and more than one-third of patients will develop acute and/or chronic graft versus host disease (GVHD) after DLI. We report two cases where DLIs were used for residual disease after posttransplant. Both of DLI went uneventful. None of the patient’s developed signs of GVHD postinfusion. Although both patients expired with different causes, none were related to DLI infusion. Information from published literature suggests that DLI should be administered early after relapse or as a prophylactic strategy in patients receiving T-cell-depleted grafts, and patients with aggressive diseases may benefit from disease reduction before DLI. However, further evidence is required to evaluate its efficacy, especially in relapsed or residual hematological malignancies.
- 1 January 2024
- Published by Medknow in Asian Journal of Transfusion Science
- Vol. 18 (1) , 124-127
Open AccessDonor lymphocyte infusions: An experience from a tertiary care center of North India
Donor lymphocyte infusions (DLIs) are often recommended products after allogeneic hematopoietic stem cell transplant to increase graft – versus – leukemia effect. More success rate of DLI has been reported in relapsed posttransplant chronic myeloid leukemia. Whatever the indication for DLI, mortality related to post-DLI infusion is 5%–20%, and more than one-third of patients will develop acute and/or chronic graft versus host disease (GVHD) after DLI. We report two cases where DLIs were used for residual disease after posttransplant. Both of DLI went uneventful. None of the patient’s developed signs of GVHD postinfusion. Although both patients expired with different causes, none were related to DLI infusion. Information from published literature suggests that DLI should be administered early after relapse or as a prophylactic strategy in patients receiving T-cell-depleted grafts, and patients with aggressive diseases may benefit from disease reduction before DLI. However, further evidence is required to evaluate its efficacy, especially in relapsed or residual hematological malignancies.
- 10 January 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (3) , 1229-1238
Novel device for automating exchange transfusions through umbilical venous route in neonates
Manually performed double-volume exchange transfusion (DVET) is tedious, error-prone, and may incur the risk of embolism. We aimed to develop a device that automates the DVET procedure performed through the umbilical venous route. We evaluated changes in blood passing through the device during DVET. We developed an electro-mechanical device with accessories (tubing and valve assembly) to perform a complete DVET. It comprises two syringes driven by a common pump that moves back and forth to withdraw aliquots of the patient’s blood and infuse equal volumes of donor blood. In tandem, it draws donor blood from a blood bank bag and pushes the patient blood drawn from the previous cycle into a waste bag, respectively. One-way duckbill valves and a two-way pinch valve ensure the separation of the donor and patient blood. A sensor detects bubbles and clots. A dashboard displays set and measured parameters. We tested the accuracy of the delivered flow rate and volume, electrical safety, embolus detection, and changes in hematological and biochemical values. The delivered flow and volume were within 5% of the set parameters. All electrical safety parameters were within normal limits. The sensor consistently detected microbubbles and clots. There were no clinically significant differences in laboratory parameters between samples drawn directly from the blood bank bag and drawn from the exit port at 80, 100, 120, and 160 s with a fixed aliquot volume. Conclusions: Our prototype of a novel device can safely automate a DVET. Further trials of this device are warranted. What is Known: • Double volume exchange transfusion is often performed manually, but this is time-consuming and error-prone. • Previous attempts at automation were not widely adopted because they involved inserting two catheters and did not have mechanisms to prevent embolism. What is New: • This novel device fully automates double volume exchange transfusions through a single-lumen umbilical venous catheter. • It prevents air and clot embolism and has a screen for input and output parameters and alarms.
- 10 January 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (3) , 1229-1238
Novel device for automating exchange transfusions through umbilical venous route in neonates
Manually performed double-volume exchange transfusion (DVET) is tedious, error-prone, and may incur the risk of embolism. We aimed to develop a device that automates the DVET procedure performed through the umbilical venous route. We evaluated changes in blood passing through the device during DVET. We developed an electro-mechanical device with accessories (tubing and valve assembly) to perform a complete DVET. It comprises two syringes driven by a common pump that moves back and forth to withdraw aliquots of the patient’s blood and infuse equal volumes of donor blood. In tandem, it draws donor blood from a blood bank bag and pushes the patient blood drawn from the previous cycle into a waste bag, respectively. One-way duckbill valves and a two-way pinch valve ensure the separation of the donor and patient blood. A sensor detects bubbles and clots. A dashboard displays set and measured parameters. We tested the accuracy of the delivered flow rate and volume, electrical safety, embolus detection, and changes in hematological and biochemical values. The delivered flow and volume were within 5% of the set parameters. All electrical safety parameters were within normal limits. The sensor consistently detected microbubbles and clots. There were no clinically significant differences in laboratory parameters between samples drawn directly from the blood bank bag and drawn from the exit port at 80, 100, 120, and 160 s with a fixed aliquot volume. Conclusions: Our prototype of a novel device can safely automate a DVET. Further trials of this device are warranted. What is Known: • Double volume exchange transfusion is often performed manually, but this is time-consuming and error-prone. • Previous attempts at automation were not widely adopted because they involved inserting two catheters and did not have mechanisms to prevent embolism. What is New: • This novel device fully automates double volume exchange transfusions through a single-lumen umbilical venous catheter. • It prevents air and clot embolism and has a screen for input and output parameters and alarms.
- 20 May 2021
- Published by Wiley in Vox Sanguinis
- Vol. 116 (10) , E71-E120
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses
- 20 May 2021
- Published by Wiley in Vox Sanguinis
- Vol. 116 (10) , E71-E120
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses